Patent · US Active

Short-acting factor VII polypeptides

US10717970B2 · kind B2 · utility

1Cited by

7References

18Claims

0Family size

Assignee

Coagulant Therapeutics Corporation · KR

Inventors

Maxine Bauzon · Hercules, US
Terry Hermiston · Corte Madera, US

Key dates

Filing date	Sep 14, 2016
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Sep 12, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.